Your browser doesn't support javascript.
loading
Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer.
Jia, Yan; Song, Yueshuai; Dong, Guolei; Hao, Chunfang; Zhao, Weipeng; Li, Shufen; Tong, Zhongsheng.
Affiliation
  • Jia Y; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, and Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Road, Tianjin, 300060, China. jiayantiantian@163.com.
  • Song Y; Department of Otolaryngology Head-Neck Surgery, Beijing Friendship Hospital, Capital Medical University, Yong'an Road, Beijing, 100032, China.
  • Dong G; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, and Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Road, Tianjin, 300060, China.
  • Hao C; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, and Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Road, Tianjin, 300060, China.
  • Zhao W; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, and Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Road, Tianjin, 300060, China.
  • Li S; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, and Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Road, Tianjin, 300060, China.
  • Tong Z; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, and Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Road, Tianjin, 300060, China. tongzhongsheng@tjmuch.com.
Sci Rep ; 9(1): 12939, 2019 09 10.
Article in En | MEDLINE | ID: mdl-31506496

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Estrogen / Gene Expression Regulation, Neoplastic / Drug Resistance, Neoplasm / Antineoplastic Agents, Hormonal / Aromatase Inhibitors / Rad51 Recombinase Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Sci Rep Year: 2019 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Estrogen / Gene Expression Regulation, Neoplastic / Drug Resistance, Neoplasm / Antineoplastic Agents, Hormonal / Aromatase Inhibitors / Rad51 Recombinase Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Sci Rep Year: 2019 Document type: Article Affiliation country: China